BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23574690)

  • 1. Cost-effectiveness of cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary artery disease in Germany.
    Boldt J; Leber AW; Bonaventura K; Sohns C; Stula M; Huppertz A; Haverkamp W; Dorenkamp M
    J Cardiovasc Magn Reson; 2013 Apr; 15(1):30. PubMed ID: 23574690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease.
    Patterson RE; Eisner RL; Horowitz SF
    Circulation; 1995 Jan; 91(1):54-65. PubMed ID: 7805219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of coronary CT angiography in patients with chest pain: Comparison with myocardial single photon emission tomography.
    Lee SP; Jang EJ; Kim YJ; Cha MJ; Park SY; Song HJ; Choi JE; Shim JI; Ahn J; Lee HJ
    J Cardiovasc Comput Tomogr; 2015; 9(5):428-37. PubMed ID: 25977116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
    Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM
    Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-minimization analysis of three decision strategies for cardiac revascularization: results of the "suspected CAD" cohort of the european cardiovascular magnetic resonance registry.
    Moschetti K; Petersen SE; Pilz G; Kwong RY; Wasserfallen JB; Lombardi M; Korosoglou G; Van Rossum AC; Bruder O; Mahrholdt H; Schwitter J
    J Cardiovasc Magn Reson; 2016 Jan; 18():3. PubMed ID: 26754743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial.
    Sharples L; Hughes V; Crean A; Dyer M; Buxton M; Goldsmith K; Stone D
    Health Technol Assess; 2007 Dec; 11(49):iii-iv, ix-115. PubMed ID: 18021576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct costs and cost-effectiveness of dual-source computed tomography and invasive coronary angiography in patients with an intermediate pretest likelihood for coronary artery disease.
    Dorenkamp M; Bonaventura K; Sohns C; Becker CR; Leber AW
    Heart; 2012 Mar; 98(6):460-7. PubMed ID: 21846767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the cost-effectiveness of stress myocardial SPECT and stress echocardiography in suspected coronary artery disease considering the prognostic value of false-negative results.
    Lee DS; Jang MJ; Cheon GJ; Chung JK; Lee MC
    J Nucl Cardiol; 2002; 9(5):515-22. PubMed ID: 12360132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of substituting dual-energy CT for SPECT in the assessment of myocardial perfusion for the workup of coronary artery disease.
    Meyer M; Nance JW; Schoepf UJ; Moscariello A; Weininger M; Rowe GW; Ruzsics B; Kang DK; Chiaramida SA; Schoenberg SO; Fink C; Henzler T
    Eur J Radiol; 2012 Dec; 81(12):3719-25. PubMed ID: 21277132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based cardiovascular magnetic resonance cost-effectiveness calculator for the detection of significant coronary artery disease.
    Pandya A; Yu YJ; Ge Y; Nagel E; Kwong RY; Bakar RA; Grizzard JD; Merkler AE; Ntusi N; Petersen SE; Rashedi N; Schwitter J; Selvanayagam JB; White JA; Carr J; Raman SV; Simonetti OP; Bucciarelli-Ducci C; Sierra-Galan LM; Ferrari VA; Bhatia M; Kelle S
    J Cardiovasc Magn Reson; 2022 Jan; 24(1):1. PubMed ID: 34986851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of coronary CT angiography versus myocardial perfusion SPECT for evaluation of patients with chest pain and no known coronary artery disease.
    Min JK; Gilmore A; Budoff MJ; Berman DS; O'Day K
    Radiology; 2010 Mar; 254(3):801-8. PubMed ID: 20177094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of Cardiovascular Magnetic Resonance in Diagnosing Coronary Artery Disease in the Australian Health Care System.
    Kozor R; Walker S; Parkinson B; Younger J; Hamilton-Craig C; Selvanayagam JB; Greenwood JP; Taylor AJ
    Heart Lung Circ; 2021 Mar; 30(3):380-387. PubMed ID: 32863111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Cost-Effectiveness of Diagnostic Tests for Assessing Stable Chest Pain: Modeled Analysis of Anatomical and Functional Strategies.
    Bertoldi EG; Stella SF; Rohde LE; Polanczyk CA
    Clin Cardiol; 2016 May; 39(5):249-56. PubMed ID: 27080921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the cost-effectiveness of stress myocardial perfusion MRI and SPECT in patients with suspected coronary artery disease.
    Iwata K; Ogasawara K
    Radiol Phys Technol; 2013 Jan; 6(1):28-34. PubMed ID: 22806543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness Analysis of Stress Cardiovascular Magnetic Resonance Imaging for Stable Chest Pain Syndromes.
    Ge Y; Pandya A; Steel K; Bingham S; Jerosch-Herold M; Chen YY; Mikolich JR; Arai AE; Bandettini WP; Patel AR; Farzaneh-Far A; Heitner JF; Shenoy C; Leung SW; Gonzalez JA; Shah DJ; Raman SV; Ferrari VA; Schulz-Menger J; Hachamovitch R; Stuber M; Simonetti OP; Kwong RY
    JACC Cardiovasc Imaging; 2020 Jul; 13(7):1505-1517. PubMed ID: 32417337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine-stress cardiac magnetic resonance imaging in suspected coronary artery disease: a net cost analysis and reimbursement implications.
    Pilz G; Patel PA; Fell U; Ladapo JA; Rizzo JA; Fang H; Gunnarsson C; Heer T; Hoefling B
    Int J Cardiovasc Imaging; 2011 Jan; 27(1):113-21. PubMed ID: 20524070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the cost-effectiveness of the most common diagnostic methods for coronary artery disease].
    Dewey M; Hamm B
    Dtsch Med Wochenschr; 2004 Jun; 129(25-26):1415-9. PubMed ID: 15213872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of cardiovascular magnetic resonance imaging compared to common strategies in the diagnosis of coronary artery disease: a systematic review.
    Azari S; Pourasghari H; Fazeli A; Ghorashi SM; Arabloo J; Rezapour A; Behzadifar M; Khorgami MR; Salehbeigi S; Omidi N
    Heart Fail Rev; 2023 Nov; 28(6):1357-1382. PubMed ID: 37532962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress Perfusion Cardiac Magnetic Resonance vs SPECT Imaging for Detection of Coronary Artery Disease.
    Arai AE; Schulz-Menger J; Shah DJ; Han Y; Bandettini WP; Abraham A; Woodard PK; Selvanayagam JB; Hamilton-Craig C; Tan RS; Carr J; Teo L; Kramer CM; Wintersperger BJ; Harisinghani MG; Flamm SD; Friedrich MG; Klem I; Raman SV; Haverstock D; Liu Z; Brueggenwerth G; Santiuste M; Berman DS; Pennell DJ
    J Am Coll Cardiol; 2023 Nov; 82(19):1828-1838. PubMed ID: 37914512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-impact of cardiac magnetic resonance imaging with Fast-SENC compared to SPECT in the diagnosis of coronary artery disease in the U.S.
    Stojanovic I; Schneider JE; Cooper J
    J Med Econ; 2019 May; 22(5):430-438. PubMed ID: 30732489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.